Silo Pharma Completes 1-for-15 Reverse Stock Split, Adjusts Authorized Shares

summarizeSummary

Silo Pharma has completed its 1-for-15 reverse stock split, effective June 2, 2026, with shares now trading on a split-adjusted basis and authorized shares proportionately reduced.

check_boxKey Events

• Reverse Stock Split Effective

  The 1-for-15 reverse stock split became effective at 4:01 p.m. ET on Tuesday, June 2, 2026, following the filing of a Certificate of Change with the Nevada Secretary of State.

• Split-Adjusted Trading Commences

  The company's common stock began trading on a split-adjusted basis on The Nasdaq Stock Market LLC when it opened on June 3, 2026.

• Authorized Shares Adjusted

  The total authorized common stock was proportionately reduced from 100,000,000 to 6,666,667 shares, with no change to the par value.

• Fractional Shares Rounded Up

  Stockholders who would have been entitled to receive fractional shares had their holdings rounded up to the next whole share.

auto_awesomeAnalysis

This filing confirms the formal execution of the previously announced 1-for-15 reverse stock split. The split became effective on June 2, 2026, with trading on a split-adjusted basis commencing today. This action is typically undertaken by micro-cap companies to increase their per-share price, often to meet minimum listing requirements for exchanges like Nasdaq and to make the stock more attractive to institutional investors. The reduction in authorized shares also impacts the company's future capital raising capacity.